BMS commercial versus research failures and screw-ups, who's leading in the count?

[Anonymous]

With the recent failure of BMS094, the nucleotide for HEP C, purchased on a Vegas-sized gamble of $2.5 billion, seems like the count could be closer depending on who you tag that with, but both sides have a questionable scorecard.